New Protocol Yields 0% Relapse in Post-Liver Transplants
Mayo Clinic researchers have developed a new protocol called PACT that resulted in a 0% alcohol relapse rate among liver transplant patients in a small study. The protocol combines medication and frequent monitoring to prevent post-transplant complications.
Why it matters
This breakthrough could significantly improve long-term survival rates for liver transplant patients, who often struggle with alcohol relapse.
PHOENIX - In a study published in the Liver Transplantation journal by the American Association for the Study of Liver Diseases, Mayo Clinic researchers found that a new proactive treatment protocol for alcohol use disorder after liver transplant resulted in a 0% heavy alcohol relapse rate among patients who followed the protocol, compared with a historical relapse rate of approximately 25%.
Scientific reporting based on peer-reviewed study findings.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in